FIELD: medicine.
SUBSTANCE: group of inventions relates to a pharmaceutical composition for stimulating bone tissue regeneration and a method of treating fractures. The pharmaceutical combination for stimulating bone tissue regeneration includes 2-ethyl-6-methyl-3-hydroxypyridine succinate and human chorionic gonadotropin (hCG) in effective quantities. A method of treating fractures involves administering to a patient a combination of 2-ethyl-6-methyl-3-hydroxypyridine succinate and hCG in effective amounts.
EFFECT: above-described group of solutions makes it possible to increase the osteogenic activity of the pharmaceutical combination, as well as reduce the likelihood of side effects caused by the systemic effect of the components on other organs and tissues.
8 cl, 9 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPLEX SALTS OF ACIDUM ACEXAMICUM, STIMULATING REGENERATION OF BONE TISSUE, ACCELERATING PROCESSES OF REPARATIVE OSTEOGENESIS, STIMULATING MINERALIZATION OF BONE TISSUE IN OSTEOPOROSIS | 2018 |
|
RU2668966C1 |
| HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
| TOOL THAT HAS THE ABILITY TO STIMULATE REPARATIVE PROCESSES OF PERIODONTAL TISSUES, AS WELL AS AN ANTIOXIDANT AND ANTI-INFLAMMATORY EFFECT, WHICH IS A 2-ETHYL-6-METHYL-3-HYDROXYPYRIDIA-2- (3-BENZOILPHENIL)-PROPANOATE, AND A PHARMACEUTICAL COMPOSITION BASED ON IT | 2022 |
|
RU2793537C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
| PHARMACOLOGICAL COMPOUND BASED ON 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM N-ACETYL-6-AMINOHEXANOATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM 3-PYRIDINOCARBONOATE AND ITS USE FOR CORRECTION AND PREVENTION OF OSTEOPOROSIS | 2023 |
|
RU2806116C1 |
| ANTIBACTERIAL AGENT | 1999 |
|
RU2157686C1 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| METHOD OF TREATING CEREBRAL OEDEMA IN PATIENTS SUFFERING FROM CHRONIC LIVER DISEASES | 2014 |
|
RU2539139C1 |
| AGENT FOR TREATING BODY IRON OVERLOAD, OR HAEMOCHROMATOSIS | 2014 |
|
RU2557959C1 |
| SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
